Tandem Diabetes Care, Inc.
TNDM
$22.72
-$0.41-1.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 254.56M | 247.22M | 290.38M | 249.25M | 240.68M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 254.56M | 247.22M | 290.38M | 249.25M | 240.68M |
| Cost of Revenue | 109.78M | 110.43M | 122.92M | 114.96M | 114.82M |
| Gross Profit | 144.78M | 136.79M | 167.46M | 134.29M | 125.86M |
| SG&A Expenses | 111.64M | 108.19M | 113.10M | 106.44M | 109.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 268.35M | 264.66M | 282.09M | 269.32M | 272.54M |
| Operating Income | -13.79M | -17.43M | 8.29M | -20.06M | -31.86M |
| Income Before Tax | -20.66M | -19.88M | 4.68M | -25.14M | -57.72M |
| Income Tax Expenses | 510.00K | 516.00K | 5.27M | -3.98M | -5.32M |
| Earnings from Continuing Operations | -21.17M | -20.39M | -589.00K | -21.17M | -52.40M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.17M | -20.39M | -589.00K | -21.17M | -52.40M |
| EBIT | -13.79M | -17.43M | 8.29M | -20.06M | -31.86M |
| EBITDA | -9.32M | -12.93M | 12.79M | -15.57M | -27.49M |
| EPS Basic | -0.31 | -0.30 | -0.01 | -0.31 | -0.78 |
| Normalized Basic EPS | -0.19 | -0.18 | 0.04 | -0.21 | -0.35 |
| EPS Diluted | -0.31 | -0.30 | -0.01 | -0.31 | -0.78 |
| Normalized Diluted EPS | -0.19 | -0.18 | 0.04 | -0.21 | -0.35 |
| Average Basic Shares Outstanding | 69.01M | 68.40M | 68.01M | 67.65M | 67.05M |
| Average Diluted Shares Outstanding | 69.01M | 68.40M | 68.01M | 67.65M | 67.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |